|
NDC00998-0408-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO PLAIN
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO TEARS
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
LACRIL SOLUTION
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
NDC00998-0404-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC11980-0045-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
NDC00058-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC58768-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
ISOPTO PLAIN
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO TEARS
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
LACRIL SOLUTION
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
NDC00998-0408-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC58768-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC00058-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC00998-0404-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC11980-0045-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
ISOPTO PLAIN
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO TEARS
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
LACRIL SOLUTION
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
NDC00998-0408-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC58768-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC00058-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC00998-0404-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC11980-0045-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
ISOPTO PLAIN
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
ISOPTO TEARS
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
LACRIL SOLUTION
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
NDC00998-0408-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC58768-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC00058-0725-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Iolab Corp
|
|
Quote
|
|
NDC00998-0404-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Alcon Laboratories, Inc.
|
|
Quote
|
|
NDC11980-0045-15
|
6505-01-153-3391
|
Hydroxypropyl Methylcellulose Op |
Allergan Inc
|
|
Quote
|
|
NDC00173-0880-25
|
6505-01-153-3394
|
Usp Thioguanine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00173-0880-25
|
6505-01-153-3394
|
Usp Thioguanine Tablets |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00081-0880-25
|
6505-01-153-3394
|
Usp Thioguanine Tablets |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00904-2735-15
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC45802-0723-90
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Clay-park Laboratories Inc
|
|
Quote
|
|
NDC00029-4088-38
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC45802-0723-90
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Clay-park Laboratories Inc
|
|
Quote
|
|
NDC00029-4088-38
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00904-2735-15
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC45802-0723-90
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Clay-park Laboratories Inc
|
|
Quote
|
|
NDC00029-4088-38
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00904-2735-15
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC45802-0723-90
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Clay-park Laboratories Inc
|
|
Quote
|
|
NDC00029-4088-38
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00904-2735-15
|
6505-01-153-3395
|
Trimethobenzamide Hydrochloride |
Major Pharmaceuticals Inc
|
|
Quote
|
|
ANCOBON
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON CAPSULES
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00004-0079-01
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON CAPSULES
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00004-0079-01
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON CAPSULES
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00004-0079-01
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON CAPSULES
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC00004-0079-01
|
6505-01-153-3401
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
NDC54569-2830-00
|
6505-01-153-3411
|
Usp Hydrocortisone Lotion |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC54569-2830-00
|
6505-01-153-3411
|
Usp Hydrocortisone Lotion |
Allscripts Healthcare Solutions Inc
|
|
Quote
|
|
NDC45802-0283-06
|
6505-01-153-3411
|
Usp Hydrocortisone Lotion |
Clay-park Laboratories Inc
|
|
Quote
|
|
NDC00182-5013-37
|
6505-01-153-3411
|
Usp Hydrocortisone Lotion |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00066-0090-04
|
6505-01-153-3411
|
Usp Hydrocortisone Lotion |
Dermik Laboratories Inc
|
|
Quote
|
|
NDC52152-0014-02
|
6505-01-153-3426
|
Dexchlorpheniramine Maleate Exte |
Amide Pharmaceutical Inc
|
|
Quote
|
|
NDC00327-0001-10
|
6505-01-153-3432
|
Oxychlorosene Sodium For Solutio |
United-guardian Inc
|
|
Quote
|
|
NDC00327-0001-10
|
6505-01-153-3432
|
Oxychlorosene Sodium For Solutio |
United-guardian Inc
|
|
Quote
|
|
NDC00327-0001-10
|
6505-01-153-3432
|
Oxychlorosene Sodium For Solutio |
United-guardian Inc
|
|
Quote
|
|
NDC00327-0001-10
|
6505-01-153-3432
|
Oxychlorosene Sodium For Solutio |
United-guardian Inc
|
|
Quote
|
|
AVENTYL
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL CAPSULES
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-0817-03
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL CAPSULES
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-0817-03
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL CAPSULES
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-0817-03
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
AVENTYL CAPSULES
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-0817-03
|
6505-01-153-3439
|
Nortriptyline Hydrochloride Caps |
Eli Lilly and Company
|
|
Quote
|
|
ITEM NUMBER: 5367
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
F-1305
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Spectrum Laboratory Products, Inc.
|
|
Quote
|
|
NDC49452-3081-02
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Spectrum Laboratory Products, Inc.
|
|
Quote
|
|
MONSELS SOLUTION
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
NDC38779-1284-08
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
805132
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
NDC51552-0357-05
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
MONSELS SOLUTION
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
1284
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
NDC38779-1284-08
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
805132
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
NDC51552-0357-05
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
MONSELS SOLUTION
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
1284
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
NDC38779-1284-08
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
805132
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
NDC51552-0357-05
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
MONSELS SOLUTION
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Fagron Inc.
|
|
Quote
|
|
1284
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
NDC38779-1284-08
|
6505-01-153-3440
|
Usp Ferric Subsulfate Solution |
Medisca Inc.
|
|
Quote
|
|
AMOXIL
|
6505-01-153-3442
|
Amoxicillin For Oral Suspension |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
AMOXIL SUSPENSION
|
6505-01-153-3442
|
Amoxicillin For Oral Suspension |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00093-4155-79
|
6505-01-153-3442
|
Amoxicillin For Oral Suspension |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
ANCOBON CAPSULES
|
6505-01-153-3444
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
ANCOBON
|
6505-01-153-3444
|
Usp Flucytosine Capsules |
R a C E Inc
|
|
Quote
|
|
NDC00004-0077-01
|
6505-01-153-3444
|
Usp Flucytosine Capsules |
Hoffmann-la Roche Inc.
|
|
Quote
|
|
DEMEROL
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Sanofi Inc
|
|
Quote
|
|
DEMEROL HCL SYRUP
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Sanofi Inc
|
|
Quote
|
|
DEMEROL SYRUP
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Sanofi Inc
|
|
Quote
|
|
97-0439
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Defense Logistics Agency
|
|
Quote
|
|
NDC00024-0332-06
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Sanofi Inc
|
|
Quote
|
|
NDC00054-3545-63
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
97-0439
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Defense Logistics Agency
|
|
Quote
|
|
NDC00054-3545-63
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
97-0439
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Defense Logistics Agency
|
|
Quote
|
|
NDC00054-3545-63
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
97-0439
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Defense Logistics Agency
|
|
Quote
|
|
NDC00054-3545-63
|
6505-01-153-3448
|
U Meperidine Hydrochloride Syrup |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00026-0613-20
|
6505-01-153-3452
|
Usp Plasma Protein Fraction |
Talecris Biotherapeutics Holdings
|
|
Quote
|
|
NDC00026-0613-20
|
6505-01-153-3452
|
Usp Plasma Protein Fraction |
Talecris Biotherapeutics Holdings
|
|
Quote
|
|
NDC00026-0613-20
|
6505-01-153-3452
|
Usp Plasma Protein Fraction |
Talecris Biotherapeutics Holdings
|
|
Quote
|
|
NDC00026-0613-20
|
6505-01-153-3452
|
Usp Plasma Protein Fraction |
Talecris Biotherapeutics Holdings
|
|
Quote
|
|
NORPRAMIN
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN TABLETS
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00068-0011-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00068-0011-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Smithkline Beecham Consumer Brands
|
|
Quote
|
|
NDC50111-0436-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Sidmak Laboratories Inc
|
|
Quote
|
|
NDC00068-0011-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00781-1972-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Sandoz Inc.
|
|
Quote
|
|
NDC00068-0011-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Smithkline Beecham Consumer Brands
|
|
Quote
|
|
NDC45963-0342-02
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Actavis Elizabeth Llc
|
|
Quote
|
|
NDC00068-0011-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Sanofi-aventis U.s. Llc
|
|
Quote
|
|
NDC00068-0011-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN TABLETS
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00781-1972-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Sandoz Inc.
|
|
Quote
|
|
NDC00068-0011-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Smithkline Beecham Consumer Brands
|
|
Quote
|
|
NDC45963-0342-02
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Actavis Elizabeth Llc
|
|
Quote
|
|
NDC00068-0011-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Sanofi-aventis U.s. Llc
|
|
Quote
|
|
NDC00068-0011-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN TABLETS
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00781-1972-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Sandoz Inc.
|
|
Quote
|
|
NDC00068-0011-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Smithkline Beecham Consumer Brands
|
|
Quote
|
|
NDC45963-0342-02
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Actavis Elizabeth Llc
|
|
Quote
|
|
NDC00068-0011-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Sanofi-aventis U.s. Llc
|
|
Quote
|
|
NDC00068-0011-01
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN TABLETS
|
6505-01-153-3463
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00015-3015-20
|
6505-01-153-3468
|
Usp Amikacin Sulfate Injection |
Sandoz Consumer Health Care Group
|
|
Quote
|
|
NDC00015-3015-20
|
6505-01-153-3468
|
Usp Amikacin Sulfate Injection |
Sandoz Consumer Health Care Group
|
|
Quote
|
|
NDC00015-3015-20
|
6505-01-153-3468
|
Usp Amikacin Sulfate Injection |
Sandoz Consumer Health Care Group
|
|
Quote
|
|
NDC00015-3015-20
|
6505-01-153-3468
|
Usp Amikacin Sulfate Injection |
Sandoz Consumer Health Care Group
|
|
Quote
|
|
NDC00044-2210-01
|
6505-01-153-3469
|
Meperidine Hydrochloride Injecti |
Knoll Pharmaceuticals
|
|
Quote
|
|
NDC00044-2210-01
|
6505-01-153-3469
|
Meperidine Hydrochloride Injecti |
Knoll Pharmaceuticals
|
|
Quote
|
|
NDC00044-2210-01
|
6505-01-153-3469
|
Meperidine Hydrochloride Injecti |
Knoll Pharmaceuticals
|
|
Quote
|
|
NDC00044-2210-01
|
6505-01-153-3469
|
Meperidine Hydrochloride Injecti |
Knoll Pharmaceuticals
|
|
Quote
|
|
K-PHOS ORIGINAL
|
6505-01-153-3470
|
Potassium Acid Phosphate Tablets |
Beach Products Inc
|
|
Quote
|
|
NDC00486-1111-05
|
6505-01-153-3470
|
Potassium Acid Phosphate Tablets |
Beach Products Inc
|
|
Quote
|
|
K-PHOS ORIGINAL
|
6505-01-153-3470
|
Potassium Acid Phosphate Tablets |
Beach Products Inc
|
|
Quote
|
|
NDC00486-1111-05
|
6505-01-153-3470
|
Potassium Acid Phosphate Tablets |
Beach Products Inc
|
|
Quote
|
|
K-PHOS ORIGINAL
|
6505-01-153-3470
|
Potassium Acid Phosphate Tablets |
Beach Products Inc
|
|
Quote
|
|
NDC00486-1111-05
|
6505-01-153-3470
|
Potassium Acid Phosphate Tablets |
Beach Products Inc
|
|
Quote
|
|
K-PHOS ORIGINAL
|
6505-01-153-3470
|
Potassium Acid Phosphate Tablets |
Beach Products Inc
|
|
Quote
|
|
NDC00486-1111-05
|
6505-01-153-3470
|
Potassium Acid Phosphate Tablets |
Beach Products Inc
|
|
Quote
|
|
NAVANE
|
6505-01-153-3474
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE CAPSULES
|
6505-01-153-3474
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00049-5710-66
|
6505-01-153-3474
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE
|
6505-01-153-3474
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE CAPSULES
|
6505-01-153-3474
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00049-5710-66
|
6505-01-153-3474
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE
|
6505-01-153-3474
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE CAPSULES
|
6505-01-153-3474
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00049-5710-66
|
6505-01-153-3474
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE
|
6505-01-153-3474
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NAVANE CAPSULES
|
6505-01-153-3474
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
NDC00049-5710-66
|
6505-01-153-3474
|
Usp Thiothixene Capsules |
Roerig Div Pfizer Inc
|
|
Quote
|
|
POLYSPORIN OINTMENT
|
6505-01-153-3486
|
Bacitracin Zinc And Polymyxin B |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00081-0798-58
|
6505-01-153-3486
|
Bacitracin Zinc And Polymyxin B |
Burroughs Wellcome Co
|
|
Quote
|
|
POLYSPORIN OINTMENT
|
6505-01-153-3486
|
Bacitracin Zinc And Polymyxin B |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00081-0798-58
|
6505-01-153-3486
|
Bacitracin Zinc And Polymyxin B |
Burroughs Wellcome Co
|
|
Quote
|
|
POLYSPORIN OINTMENT
|
6505-01-153-3486
|
Bacitracin Zinc And Polymyxin B |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00081-0798-58
|
6505-01-153-3486
|
Bacitracin Zinc And Polymyxin B |
Burroughs Wellcome Co
|
|
Quote
|
|
POLYSPORIN OINTMENT
|
6505-01-153-3486
|
Bacitracin Zinc And Polymyxin B |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00081-0798-58
|
6505-01-153-3486
|
Bacitracin Zinc And Polymyxin B |
Burroughs Wellcome Co
|
|
Quote
|
|
NDC00015-7402-99
|
6505-01-153-3490
|
Usp Ampicillin Sodium |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00015-7402-00
|
6505-01-153-3490
|
Usp Ampicillin Sodium |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00015-7402-99
|
6505-01-153-3490
|
Usp Ampicillin Sodium |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00015-7402-00
|
6505-01-153-3490
|
Usp Ampicillin Sodium |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00015-7402-99
|
6505-01-153-3490
|
Usp Ampicillin Sodium |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00015-7402-00
|
6505-01-153-3490
|
Usp Ampicillin Sodium |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00015-7402-99
|
6505-01-153-3490
|
Usp Ampicillin Sodium |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00015-7402-00
|
6505-01-153-3490
|
Usp Ampicillin Sodium |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00002-2542-02
|
6505-01-153-3499
|
Usp Atropine Sulfate Tablets |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-2542-02
|
6505-01-153-3499
|
Usp Atropine Sulfate Tablets |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-2542-02
|
6505-01-153-3499
|
Usp Atropine Sulfate Tablets |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-2542-02
|
6505-01-153-3499
|
Usp Atropine Sulfate Tablets |
Eli Lilly and Company
|
|
Quote
|
|
NDC00517-2220-25
|
6505-01-153-3509
|
Potassium Chloride For Injection |
Luitpold Pharmaceuticals Inc
|
|
Quote
|
|
NDC00469-0067-15
|
6505-01-153-3509
|
Potassium Chloride For Injection |
Lyphomed Inc
|
|
Quote
|
|
NDC00469-0067-15
|
6505-01-153-3509
|
Potassium Chloride For Injection |
Lyphomed Inc
|
|
Quote
|
|
NDC00517-2220-25
|
6505-01-153-3509
|
Potassium Chloride For Injection |
Luitpold Pharmaceuticals Inc
|
|
Quote
|
|
NDC00469-0067-15
|
6505-01-153-3509
|
Potassium Chloride For Injection |
Lyphomed Inc
|
|
Quote
|
|
NDC00517-2220-25
|
6505-01-153-3509
|
Potassium Chloride For Injection |
Luitpold Pharmaceuticals Inc
|
|
Quote
|
|
NDC00469-0067-15
|
6505-01-153-3509
|
Potassium Chloride For Injection |
Lyphomed Inc
|
|
Quote
|
|
NDC00517-2220-25
|
6505-01-153-3509
|
Potassium Chloride For Injection |
Luitpold Pharmaceuticals Inc
|
|
Quote
|
|
PAVABID
|
6505-01-153-3516
|
Papaverine Hydrochloride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
PAVABID CAPSULES
|
6505-01-153-3516
|
Papaverine Hydrochloride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00088-1555-47
|
6505-01-153-3516
|
Papaverine Hydrochloride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
PAVABID
|
6505-01-153-3516
|
Papaverine Hydrochloride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
PAVABID CAPSULES
|
6505-01-153-3516
|
Papaverine Hydrochloride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00088-1555-47
|
6505-01-153-3516
|
Papaverine Hydrochloride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
PAVABID
|
6505-01-153-3516
|
Papaverine Hydrochloride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
PAVABID CAPSULES
|
6505-01-153-3516
|
Papaverine Hydrochloride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00088-1555-47
|
6505-01-153-3516
|
Papaverine Hydrochloride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
PAVABID
|
6505-01-153-3516
|
Papaverine Hydrochloride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
PAVABID CAPSULES
|
6505-01-153-3516
|
Papaverine Hydrochloride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00088-1555-47
|
6505-01-153-3516
|
Papaverine Hydrochloride Tablets |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC00781-1489-01
|
6505-01-153-3549
|
Amitriptyline Hydrochloride Tabl |
Sandoz Inc.
|
|
Quote
|
|
NDC00378-2675-01
|
6505-01-153-3549
|
Amitriptyline Hydrochloride Tabl |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC47679-0722-35
|
6505-01-153-3549
|
Amitriptyline Hydrochloride Tabl |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00781-1489-01
|
6505-01-153-3549
|
Amitriptyline Hydrochloride Tabl |
Geneva Pharmaceuticals Inc
|
|
Quote
|
|
NDC00053-3520-04
|
6505-01-153-3558
|
Usp Thyroid Tablets |
Armour Pharmaceutical Co
|
|
Quote
|
|
NDC00053-3520-04
|
6505-01-153-3558
|
Usp Thyroid Tablets |
Armour Pharmaceutical Co
|
|
Quote
|
|
NDC00053-3520-04
|
6505-01-153-3558
|
Usp Thyroid Tablets |
Armour Pharmaceutical Co
|
|
Quote
|
|
NDC00053-3520-04
|
6505-01-153-3558
|
Usp Thyroid Tablets |
Armour Pharmaceutical Co
|
|
Quote
|
